JP2018504141A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018504141A5 JP2018504141A5 JP2017556782A JP2017556782A JP2018504141A5 JP 2018504141 A5 JP2018504141 A5 JP 2018504141A5 JP 2017556782 A JP2017556782 A JP 2017556782A JP 2017556782 A JP2017556782 A JP 2017556782A JP 2018504141 A5 JP2018504141 A5 JP 2018504141A5
- Authority
- JP
- Japan
- Prior art keywords
- government
- awarded
- health
- certain rights
- national institutes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562105284P | 2015-01-20 | 2015-01-20 | |
| US62/105,284 | 2015-01-20 | ||
| PCT/US2016/013765 WO2016118433A1 (en) | 2015-01-20 | 2016-01-17 | Detargeted adenovirus variants and related methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018504141A JP2018504141A (ja) | 2018-02-15 |
| JP2018504141A5 true JP2018504141A5 (cg-RX-API-DMAC7.html) | 2019-02-07 |
Family
ID=56417617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017556782A Pending JP2018504141A (ja) | 2015-01-20 | 2016-01-17 | 非標的化アデノウイルス変異体および関連する方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (3) | US10376549B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3247807B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2018504141A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016118433A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014236207B2 (en) | 2013-03-14 | 2019-05-23 | Salk Institute For Biological Studies | Oncolytic adenovirus compositions |
| ES2933174T3 (es) | 2016-02-23 | 2023-02-02 | Salk Inst For Biological Studi | Expresión génica exógena en adenovirus terapéutico para mínimo impacto sobre la cinética viral |
| CA3013637A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
| EP4190906B1 (en) | 2016-03-31 | 2025-08-20 | The European Molecular Biology Laboratory | Engineered polypeptides derived from adenoviral fibre protein and vlps containing the polypeptides |
| WO2018111767A1 (en) | 2016-12-12 | 2018-06-21 | Salk Institute For Biological Studies | Tumor-targeting synthetic adenoviruses and uses thereof |
| GB201802539D0 (en) * | 2018-02-16 | 2018-04-04 | Univ College Cardiff Consultants Ltd | Modified adenoviruses |
| EP3775175A4 (en) | 2018-04-09 | 2022-02-09 | Salk Institute for Biological Studies | ONCOLYTIC ADENOVIRUS COMPOSITIONS WITH IMPROVED REPLICATION PROPERTIES |
| EP3812465A1 (en) | 2019-10-21 | 2021-04-28 | Universität Ulm | Adenovirus comprising a modified adenovirus hexon protein |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1601438A (cg-RX-API-DMAC7.html) | 1968-10-17 | 1970-08-24 | ||
| AU1449792A (en) * | 1991-02-14 | 1992-09-15 | La Jolla Cancer Research Foundation | A novel integrin specificity for the hiv tat protein |
| US5559099A (en) | 1994-09-08 | 1996-09-24 | Genvec, Inc. | Penton base protein and methods of using same |
| WO2000015823A1 (en) | 1998-09-11 | 2000-03-23 | Genvec, Inc. | Alternatively targeted adenovirus |
| US20060057553A1 (en) * | 2000-05-30 | 2006-03-16 | Estuardo Aguilar-Cordova | Chimeric viral vectors for gene therapy |
| EP1572718A4 (en) * | 2001-04-04 | 2006-03-15 | Univ Rochester | ALPHA NU BETA-3 INTEGRIN BINDING POLYPEPTIDE ANTIBODY AND THEIR USE |
| AU2002343901A1 (en) * | 2001-09-29 | 2003-04-14 | Kim, Joo-Hang | Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus |
| JP4488290B2 (ja) * | 2002-01-24 | 2010-06-23 | ザ・スクリップス・リサーチ・インスティテュート | 効率的ターゲティングのためのファイバーシャフト変異 |
| JP4328116B2 (ja) * | 2003-03-25 | 2009-09-09 | 国立医薬品食品衛生研究所長 | 変異型アデノウイルスベクター |
| US20060281090A1 (en) * | 2003-05-01 | 2006-12-14 | University Of Washington Uw Tech Transfer- Invention Licensing | Capsid-modified adenovirus vectors and methods of using the same |
| WO2007094653A1 (en) * | 2006-02-13 | 2007-08-23 | Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg | Adenovirus particles having a chimeric adenovirus spike protein, use thereof and methods for producing such particles. |
| CN102014948A (zh) * | 2008-02-07 | 2011-04-13 | 安德鲁·贝克 | 腺病毒向性的调节 |
| JP5980117B2 (ja) * | 2009-11-09 | 2016-08-31 | ジェンヴェック，インコーポレーテッド | サルアデノウイルスベクターの増殖方法 |
-
2016
- 2016-01-17 JP JP2017556782A patent/JP2018504141A/ja active Pending
- 2016-01-17 EP EP16740545.5A patent/EP3247807B1/en not_active Not-in-force
- 2016-01-17 US US15/537,392 patent/US10376549B2/en active Active
- 2016-01-17 WO PCT/US2016/013765 patent/WO2016118433A1/en not_active Ceased
-
2019
- 2019-07-02 US US16/460,160 patent/US11364306B2/en active Active
-
2022
- 2022-06-07 US US17/805,825 patent/US20230001014A1/en not_active Abandoned